Field Trip’s Downfall: Too Early, Too Aggressive, Too Extravagant?

Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use...

Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders Discussing Expansion...

Silo Pharma Announces filing of Patent for Treatment of Fibromyalgia

Psychedelic Research Bulletin: February2023

Reunion Neuroscience Abstract Accepted for Poster Presentation at 2023 ASCP Annual...

Numinus Launches the Practitioner Certification Pathway – a Complete Psychedelic-Assisted Therapy...

Dispatch from ECNP New Frontiers: Psychedelics (Psychedelic Bulletin #134)

Psychedelics Weekly – More Trouble For Field Trip Health, Ketamine Wellness...

atai Life Sciences Reports Fourth Quarter and Full Year 2022 Financial...

Load more